McCulloch PB - Search Results

1

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

Rusthoven JJ, Quirt IC, Iscoe NA, McCulloch PB, James KW, Lohmann RC, Jensen J, Burdette-Radoux S, Bodurtha AJ, Silver HK, Verma S, Armitage GR, Zee B, Bennett K. Rusthoven JJ, et al. Among authors: mcculloch pb. J Clin Oncol. 1996 Jul;14(7):2083-90. doi: 10.1200/JCO.1996.14.7.2083. J Clin Oncol. 1996. PMID: 8683240 Clinical Trial.

2

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

Quirt IC, Shelley WE, Pater JL, Bodurtha AJ, McCulloch PB, McPherson TA, Paterson AH, Prentice R, Silver HK, Willan AR, et al. Quirt IC, et al. Among authors: mcculloch pb. J Clin Oncol. 1991 May;9(5):729-35. doi: 10.1200/JCO.1991.9.5.729. J Clin Oncol. 1991. PMID: 2016615 Clinical Trial.

3

A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study.

Eisenhauer E, Kerr I, Bodurtha A, Iscoe N, McCulloch P, Pritchard K, Quirt I. Eisenhauer E, et al. Invest New Drugs. 1985;3(3):303-5. doi: 10.1007/BF00179436. Invest New Drugs. 1985. PMID: 4066224

4

Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.

Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ. Clark RM, et al. J Natl Cancer Inst. 1996 Nov 20;88(22):1659-64. doi: 10.1093/jnci/88.22.1659. J Natl Cancer Inst. 1996. PMID: 8931610 Clinical Trial.

5

Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer.

Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS, et al. Clark RM, et al. Among authors: mcculloch pb. J Natl Cancer Inst. 1992 May 6;84(9):683-9. doi: 10.1093/jnci/84.9.683. J Natl Cancer Inst. 1992. PMID: 1314910 Clinical Trial.

6

Systemic adjuvant therapy for node-negative breast cancer.

Ginsburg AD, Perrault DJ, Pritchard KI, Browman GP, McCulloch PB, Skillings J. Ginsburg AD, et al. Among authors: mcculloch pb. CMAJ. 1989 Sep 1;141(5):381-7. CMAJ. 1989. PMID: 2670170 Free PMC article. Review.

7

Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.

McCulloch PB, Dent PB, Blajchman M, Muirhead WM, Price RA. McCulloch PB, et al. Can Med Assoc J. 1977 Jul 9;117(1):33-6. Can Med Assoc J. 1977. PMID: 861909 Free PMC article.

8

Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.

McCulloch PB, Eisenhauer EA, Shibata HR, Young VP. McCulloch PB, et al. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):771-2. Cancer Treat Rep. 1987. PMID: 2955887 Clinical Trial. No abstract available.

9

Cellular morphology of human malignant melanoma in primary culture.

Liao SK, Dent PB, McCulloch PB. Liao SK, et al. Among authors: mcculloch pb. In Vitro. 1976 Sep;12(9):654-7. doi: 10.1007/BF02797466. In Vitro. 1976. PMID: 1010531

10

Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.

Lui VK, Karpuchas J, Dent PB, McCulloch PB, Blajchman MA. Lui VK, et al. Among authors: mcculloch pb. Br J Cancer. 1975 Sep;32(3):323-30. doi: 10.1038/bjc.1975.230. Br J Cancer. 1975. PMID: 1233077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters